Phenylketonuria (PKU) is an inborn error of metabolism that results from a deficiency of phenylalanine hydroxylase (PAH). Discover the latest research on phenylketonuria here.

May 2, 2020
Open Access

A Review on Electrochemical Sensors and Biosensors Used in Phenylalanine Electroanalysis

Ancuta Dinu, Constantin Apetrei
April 30, 2020
Open Access

The first study of successful pregnancies in Chinese patients with Phenylketonuria

BMC Pregnancy and Childbirth
Lin WangMing Shen
July 1, 2020

Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up

Molecular Genetics and Metabolism
Barbara K BurtonPAL-002 and PAL-004 Investigators
May 20, 2020

Body fat percentage in adolescents with phenylketonuria and associated factors

Molecular Genetics and Metabolism Reports
Giovanna Caliman CamattaAna Lúcia Pimenta Starling
April 14, 2020
Open Access

Health-related quality of life of parents of children with phenylketonuria in Tehran Province, Islamic Republic of Iran

Eastern Mediterranean Health Journal = La Revue De Santé De La Méditerranée Orientale = Al-Majallah Al-ṣiḥḥīyah Li-sharq Al-mutawassiṭ
Koorosh EtemadMansoureh Lotfi
July 2, 2020
Open Access

PKU dietary handbook to accompany PKU guidelines

Orphanet Journal of Rare Diseases
Anita MacDonaldFrancjan J van Spronsen
June 28, 2020

Retinal nerve fibre layer thickness associates with phenylketonuria control and cognition

Journal of Medical Genetics
Jan Krzysztof NowakJarosław Walkowiak
April 19, 2020

Animal Model Contributions to Congenital Metabolic Disease

Advances in Experimental Medicine and Biology
Corinna A Moro, Wendy Hanna-Rose
April 30, 2020

Health Related Quality of Life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire

Molecular Genetics and Metabolism Reports
András Gellért BartaPéter Reismann
June 11, 2020
Open Access

Anthropometry and bone mineral density in treated and untreated hyperphenylalaninemia

Endocrine Connections
Mojca Zerjav TansekMagdalena Avbelj Stefanija
April 8, 2020

Assessment of Anthropometric Indices in Patients with Phenylketonuria

Iranian Journal of Child Neurology
Marjan ShakibaAsieh Mosallanejad
May 13, 2020
Open Access

Food insecurity in females with phenylketonuria

JIMD Reports
Kathryn E CoakleyRani H Singh
July 1, 2020
Open Access

Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe

Kimber van VlietM Rebecca Heiner-Fokkema
June 12, 2020
Open Access

Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU)

Molecular Frontiers Journal
Cary O Harding
May 3, 2020
Open Access

Development of an inventory to assess perceived barriers related to PKU treatment

Journal of Patient-reported Outcomes
Katia Irie TeruyaIda Vanessa Doederlein Schwartz

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.


Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

© 2020 Meta ULC. All rights reserved